Rhythm Biosciences Ltd
RHY
Company Profile
Business description
Rhythm Biosciences Ltd is a medical diagnostics technology company. It is engaged in developing and commercializing Australian medical diagnostics technology for sale to national and international markets. The product includes ColoSTAT a proposed diagnostic blood test for screening for colorectal cancer. The company operates predominantly in one business and geographical segment which is the research and development of biosciences in Australia.
Contact
30 Flemington Road
Bio21 Institute
Parkville
MelbourneVIC3010
AUST: +61 382562880
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
30 June 2026
Employees
Stocks News & Analysis
stocks
This ASX supermarkets business is now underperforming its largest competitor
Competition restrains long-term margins.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,923.80 | 30.30 | -0.34% |
| CAC 40 | 7,976.12 | 138.72 | -1.71% |
| DAX 40 | 23,991.27 | 301.11 | -1.24% |
| Dow JONES (US) | 49,012.36 | 486.91 | -0.98% |
| FTSE 100 | 10,363.93 | 14.89 | -0.14% |
| HKSE | 26,095.88 | 319.35 | 1.24% |
| NASDAQ | 24,992.77 | 121.68 | -0.48% |
| Nikkei 225 | 59,513.12 | 228.20 | 0.38% |
| NZX 50 Index | 13,097.68 | 58.48 | 0.45% |
| S&P 500 | 7,191.60 | 38.52 | -0.53% |
| S&P/ASX 200 | 8,697.10 | 28.50 | -0.33% |
| SSE Composite Index | 4,112.16 | 4.65 | 0.11% |